Pier Lambiase, EHRA 2019 – Sudden Death Risk in Non-ischaemic Cardiomyopathy
Professor Pier Lambiase (Consultant Electrophysiologist, University College London and Barts Heart Centre, London, UK) joins touchCARDIO at the annual European Heart Rhythm (EHRA) 2019 congress in Lisbon to discuss the risks of sudden cardiac death and new techniques to improve prevention, diagnosis and monitoring.
Filmed at EHRA 2019, Lisbon.
Speaker’s Disclosures: Professor Pier Lambiase has received research grants from Abbott, Boston Scientific and Medtronic.
- Sudden cardiac death remains a significant global healthcare concern – please explain its risk in patients with non-ischaemic cardiomyopathy. (0:14)
- How can patients with non-ischaemic cardiomyopathy be stratified to help assess risk and improve prevention of sudden cardiac death? (0:39)
- What imaging techniques can be employed to facilitate diagnosis and monitoring? (1:47)
- What are the key factors in improving prevention of sudden cardiac death in patients with non-ischaemic cardiomyopathy? (2:39)
- Please summarise your highlights of the EHRA 2019 congress so far. (3:24)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Share this Video
Related Videos In Cardiovascular Disease
John Forrest, ACC 2023: Evolut low risk trial, transcatheter versus surgical aortic valve replacement in patients at low surgical risk
The Evolut low risk trial aimed to compare transcatheter versus surgical aortic valve replacement in patients who were at low risk for surgery. In this touchCARDIO interview, we speak with Dr John Forrest (Yale New Haven Hospital, Yale University, New Haven, CT, USA) to discuss the eligibility criteria, the key findings and the outlook for […]
John Forrest, ACC 2023: The treatment paradigm for patients with aortic stenosis
The treatment paradigm for aortic stenosis has developed dramatically in the past decade. In this touchCARDIO interview, we speak with Dr John Forrest (Yale New Haven Hospital, Yale University, New Haven, CT, USA) to outline and discuss the developments. Dr Forrest presented an abstract entitled ‘Transcatheter Versus Surgical Aortic Valve Replacement In Aortic Stenosis Patients […]
Steven Nissen, ACC 2023: Lipid-lowering therapies – current and future options
Many lipid-lowering therapies exist, such as statins to manage and reduce lipid levels. While statins are the most commonly used medication, some patients may need additional interventions to lower their LDL cholesterol levels. In this touchCARDIO interview, we speak with Prof. Steven Nissen (Cleveland Clinic, Cleveland, OH, USA) to explore current and developing novel lipid-lowering […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!